BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 27590221)

  • 1. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
    Vidal-Petiot E; Ford I; Greenlaw N; Ferrari R; Fox KM; Tardif JC; Tendera M; Tavazzi L; Bhatt DL; Steg PG;
    Lancet; 2016 Oct; 388(10056):2142-2152. PubMed ID: 27590221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.
    Li J; Somers VK; Gao X; Chen Z; Ju J; Lin Q; Mohamed EA; Karim S; Xu H; Zhang L
    JAMA Netw Open; 2021 Feb; 4(2):e2037554. PubMed ID: 33595663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.
    Cooper-DeHoff RM; Gong Y; Handberg EM; Bavry AA; Denardo SJ; Bakris GL; Pepine CJ
    JAMA; 2010 Jul; 304(1):61-8. PubMed ID: 20606150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and Hypertension.
    Vidal-Petiot E; Greenlaw N; Ford I; Ferrari R; Fox KM; Tardif JC; Tendera M; Parkhomenko A; Bhatt DL; Steg PG
    Hypertension; 2018 Jan; 71(1):168-176. PubMed ID: 29084876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial).
    Khan NA; Rabkin SW; Zhao Y; McAlister FA; Park JE; Guan M; Chan S; Humphries KH
    Hypertension; 2018 May; 71(5):840-847. PubMed ID: 29581214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2014 Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST study.
    Bangalore S; Gong Y; Cooper-DeHoff RM; Pepine CJ; Messerli FH
    J Am Coll Cardiol; 2014 Aug; 64(8):784-93. PubMed ID: 25145522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target Blood Pressure in Patients with Diabetes: Asian Perspective.
    Park S; Kario K; Park CG; Huang QF; Cheng HM; Hoshide S; Wang JG; Chen CH;
    Yonsei Med J; 2016 Nov; 57(6):1307-11. PubMed ID: 27593856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.
    Blood Pressure Lowering Treatment Trialists' Collaboration
    Lancet; 2021 May; 397(10285):1625-1636. PubMed ID: 33933205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
    Messerli FH; Mancia G; Conti CR; Hewkin AC; Kupfer S; Champion A; Kolloch R; Benetos A; Pepine CJ
    Ann Intern Med; 2006 Jun; 144(12):884-93. PubMed ID: 16785477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood Pressure at 6 Months After Acute Myocardial Infarction and Outcomes at 2 Years: The Perils Associated With Excessively Low Blood Pressures.
    Song PS; Lee SH; Jeon KH; Hahn JY; Hur SH; Rha SW; Yoon CH; Jeong MH; Jeong JO; Seong IW; Song YB; Gwon HC;
    Can J Cardiol; 2020 Oct; 36(10):1641-1648. PubMed ID: 32413339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diastolic Hypotension May Attenuate Benefits from Intensive Systolic Targets: Secondary Analysis of a Randomized Controlled Trial.
    Lee TC; Cavalcanti RB; McDonald EG; Pilote L; Brophy JM
    Am J Med; 2018 Oct; 131(10):1228-1233.e1. PubMed ID: 29906425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systolic blood pressure and cardiovascular outcomes during treatment of hypertension.
    Weber MA; Bakris GL; Hester A; Weir MR; Hua TA; Zappe D; Dahlof B; Velazquez EJ; Pitt B; Jamerson K
    Am J Med; 2013 Jun; 126(6):501-8. PubMed ID: 23541376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis.
    Blood Pressure Lowering Treatment Trialists' Collaboration
    Lancet; 2021 Sep; 398(10305):1053-1064. PubMed ID: 34461040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
    Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
    Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Achieved Blood Pressure on First Stroke in Uncomplicated Grade 1 Hypertension.
    Qin X; Li Y; Sun N; He M; Tang G; Yin D; Wang J; Liang M; Wang B; Huo Y; Xu X; Xu X; Hou FF
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study.
    Vamos EP; Harris M; Millett C; Pape UJ; Khunti K; Curcin V; Molokhia M; Majeed A
    BMJ; 2012 Aug; 345():e5567. PubMed ID: 22936794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial.
    He J; Ouyang N; Guo X; Sun G; Li Z; Mu J; Wang DW; Qiao L; Xing L; Ren G; Zhao C; Yang R; Yuan Z; Wang C; Shi C; Liu S; Miao W; Li G; Chen CS; Sun Y;
    Lancet; 2023 Mar; 401(10380):928-938. PubMed ID: 36871573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is systolic blood pressure below 150 mm Hg an appropriate goal for primary prevention of cardiovascular events among elderly population?
    Mohebi R; Mohebi A; Ghanbarian A; Momenan A; Azizi F; Hadaegh F
    J Am Soc Hypertens; 2014 Jul; 8(7):491-7. PubMed ID: 25064771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry.
    Vidal-Petiot E; Sorbets E; Bhatt DL; Ducrocq G; Elbez Y; Ferrari R; Ford I; Tardif JC; Tendera M; Fox KM; Steg PG
    Eur Heart J; 2018 Nov; 39(43):3855-3863. PubMed ID: 30124796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.